IRCT20201210049672N1
Recruiting
Phase 3
Comparison of the efficacy of inhaled heparin/N-acetylcysteine, N-acetylcystein alone, and placepo for the treatment of COVID-19 patients admitted to the hospital
Vice-Chancellery for Research Hormozgan University of Medical Sciences0 sites25 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- COVID-19.
- Sponsor
- Vice-Chancellery for Research Hormozgan University of Medical Sciences
- Enrollment
- 25
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Definitive COVID\-19 diagnosis based on PCR results
- •Admission to the intensive care unit
Exclusion Criteria
- •Hypersensitivity to heparin and N\-acetyl cysteine
- •Coagulopathies
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Investigation of the effect of inhaled heparin in the treatment of patients with adult respiratory distress syndrome hospitalized in the intensive care unitAcute respiratory distress syndrome.Acute respiratory distress syndromeIRCT20190506043492N4Ahvaz University of Medical Sciences60
Completed
Phase 2
Comparison of Heparin and Clexane in Thrombosis Prevention after CraniotomyDeep Vein Thrombosis.Phlebitis and Thrombophlebitis of other Deep Vessels of Lower ExtremitiesI 80.2IRCT2012102711274N1Vice Chancellor for Research, University of Medical Sciences154
Not yet recruiting
Phase 2
The Evaluation of effectiveness of heparin nebulizer in reduction of respiratory distress in patients with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20210513051275N1Islamic Azad University60
Completed
Phase 3
Evaluation of the effect of nebulized heparin on days without ventilator in intensive care unit patientsAcute respiratory distress syndrom.Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vaporsJ68.3IRCT20211010052718N2Mazandaran University of Medical Sciences74
Recruiting
Phase 3
Effect of heparin and enoxaparin in patients undergoing primary angioplastyAcute myocardial infarction.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarctionIRCT20220809055645N4Rasht University of Medical Sciences171